Sanders Capital’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-4,922,450
Closed -$384M 48
2016
Q2
$384M Sell
4,922,450
-315,416
-6% -$22.5M 3.19% 14
2016
Q1
$288M Buy
5,237,866
+177,751
+4% +$9.68M 2.49% 19
2015
Q4
$313M Buy
5,060,115
+180,900
+4% +$11.4M 2.86% 16
2015
Q3
$308M Buy
4,879,215
+21,000
+0.4% +$1.5M 3.09% 12
2015
Q2
$355M Buy
4,858,215
+5,161
+0.1% +$373K 3.35% 10
2015
Q1
$317M Sell
4,853,054
-95,400
-2% -$6.34M 3.13% 13
2014
Q4
$322M Buy
4,948,454
+21,700
+0.4% +$1.4M 3.17% 10
2014
Q3
$296M Buy
4,926,754
+514,934
+12% +$33.6M 3.17% 8
2014
Q2
$306M Buy
4,411,820
+74,000
+2% +$4.8M 3.4% 8
2014
Q1
$284M Sell
4,337,820
-520,536
-11% -$33.9M 3.29% 9
2013
Q4
$301M Buy
4,858,356
+186,700
+4% +$10.8M 3.58% 7
2013
Q3
$251M Sell
4,671,656
-4,400
-0.1% -$227K 3.44% 10
2013
Q2
$213M Buy
+4,676,056
New +$203M 2.91% 14

Other funds holding STJ

Sanders Capital's STJ Position: Q3 2016 in Review

Sanders Capital sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 4,922,450 shares — an estimated $384M sold.

Sanders Capital first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $384M in Q2 2016. 571 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Sanders Capital reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Sanders Capital sold 4,922,450 St Jude Medical shares in Q3 2016, an estimated $384M.
  • Sanders Capital first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Sanders Capital's St Jude Medical position peaked at $384M in Q2 2016.
  • 571 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Sanders Capital's 13F filing for Q3 2016, filed 1 Nov 2016.